Maternal smoking during pregnancy and children's cognitive and physical development: a causal risk factor?
There remains considerable debate regarding the effects of maternal smoking during pregnancy on children's growth and development. Evidence that exposure to maternal smoking during pregnancy is associated with numerous adverse outcomes is contradicted by research suggesting that these associations are spurious. The authors investigated the relation between maternal smoking during pregnancy and 14 developmental outcomes of children from birth through age 7 years, using data from the Collaborative Perinatal Project (1959-1974; n = 52,919). In addition to adjusting for potential confounders measured contemporaneously with maternal smoking, the authors fitted conditional fixed-effects models among siblings that controlled for unmeasured confounders. Results from the conditional analyses indicated a birth weight difference of -85.63 g associated with smoking of >or=20 cigarettes daily during pregnancy (95% confidence interval: -131.91, -39.34) and 2.73 times' higher odds of being overweight at age 7 years (95% confidence interval: 1.30, 5.71). However, the associations between maternal smoking and 12 other outcomes studied (including Apgar score, intelligence, academic achievement, conduct problems, and asthma) were entirely eliminated after adjustment for measured and unmeasured confounders. The authors conclude that the hypothesized effects of maternal smoking during pregnancy on these outcomes either are not present or are not distinguishable from a broader range of familial factors associated with maternal smoking.
Gilman
Stephen E
SE
Department of Society, Human Development, and Health, Harvard School of Public Health, Boston, MA 02115, USA. sgilman@hsph.harvard.edu
Gardener
Hannah
H
Buka
Stephen L
SL
D001519:Behavior / Q000187:drug effects; D001900:Boston / Q000453:epidemiology; D002648:Child; D002657:Child Development / Q000187:drug effects; D002675:Child, Preschool; D003071:Cognition / Q000187:drug effects; D015331:Cohort Studies; D016001:Confidence Intervals; D005260:Female; D005431:Florida / Q000453:epidemiology; D006128:Growth / Q000187:drug effects; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007360:Intelligence / Q000187:drug effects; D008297:Male; D009035:Mothers / Q000706:statistics & numerical data; D016017:Odds Ratio; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology; D011297:Prenatal Exposure Delayed Effects / Q000453:epidemiology / Q000209:etiology*; D012237:Rhode Island / Q000453:epidemiology; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects*